Objectives To characterize the psychosocial profiles of adult women diagnosed with Turner syndrome before (early diagnosis) and at or after (late diagnosis) 13 years of age.
T urner syndrome is a common genetic disorder characterized by partial or complete absence of 1 X chromosome, affecting approximately 1 in 2000 female births. 1 Clinical features in women with Turner syndrome may include short stature, ovarian failure, and dysmorphia, as well as medical risks such as obesity, cardiac malformations, and renal abnormalities. 2 Clinical manifestations differ by individual and, as a result, age at diagnosis is highly variable. Schoemaker et al found 55.5% of females received Turner syndrome diagnoses at or after age 13 years (unpublished data). 3 Several studies have found that growth hormone (GH) responsiveness decreases as initiation age increases. 4, 5 However, there is a paucity of studies examining age at Turner syndrome diagnosis as a factor of psychosocial development. Adolescence is a vulnerable time for girls with Turner syndrome, and diagnoses received during this time potentially disrupt a critical period for identity formation. 6 Studies indicate that self-perception declines in early adolescence, in part owing to displeasure with physical manifestations of Turner syndrome (eg, amenorrhea, minimal breast development, short stature), which become increasingly evident at this time. 7, 8 Psychological profiles of girls and women with Turner syndrome frequently reveal depression and negative self-image, often beginning in adolescence and extending into adulthood. 9, 10 Previous research has shown age at Turner syndrome diagnosis influences psychological well-being. However, research has yet to evaluate the long-term effect of age at diagnosis on specific psychosocial domains. 11 This study examined psychosocial development in relation to Turner syndrome diagnoses received before and at or after 13 years of age, which represents the national average age of menarche onset and a posited vital age for identity development. 6, 12 BDI-II Beck Depression Inventory-II GED General Equivalency Diploma GH Growth hormone NIH National Institutes of Health OPHI-II Occupational Performance History Interview-II OSA Occupational Self-Assessment PAL-M Profile of Adaptation to Life-Medical
Methods
Women with a diagnosis of Turner syndrome participated in the cross-sectional study "Turner Syndrome: Genotype & Phenotype" at the National Institutes of Health (NIH). This study was part of a multidisciplinary, longitudinal project conducted through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, exploring mechanisms causing Turner syndrome features (ClinicalTrials.gov: NCT00006334). The current study implemented occupational and vocational therapy measures to investigate psychosocial profiles within the population with Turner syndrome.
Participants were recruited through medical journal advertisements, physician referrals, Turner syndrome advocacy groups, and ClinicalTrials.gov online postings. Eligibility requirements included nonpregnant phenotypic females, at least 10 years of age, evidence of a X-chromosomal abnormality (or ≥80% 45, X lymphocytes for those with a 45, X/46XX karyotype), and no coexisting autosomal defects. Blood samples taken at screening confirmed participant karyotype. Participants provided individual or parental informed consent. The National Institute of Child Health and Human Development Institutional Review Board approved this research protocol (2000-CH-0219).
Women with a Turner syndrome diagnosis (n = 160) enrolled between December 2008 and June 2012. This study limited participant age to 22 years and older to examine the psychosocial profiles of adult women. This analysis omitted 50 participants on the following bases: non-Turner syndrome karyotype (n = 4), incomplete testing owing to intellectual disability (n = 1), and pediatric age range (n = 45), as defined by the US Department of Health and Human Services. 13 The final analysis included 110 participants.
Participants underwent 5 days of comprehensive medical and psychological inpatient examination at the NIH Clinical Center in Bethesda, Maryland. Two registered occupational therapists administered the Beck Depression Inventory-II (BDI-II), Occupational Self-Assessment (OSA), and Occupational Performance History Interview-II (OPHI-II) during a 90-minute assessment. [14] [15] [16] A certified rehabilitation counselor administered the Profile of Adaptation to Life-Medical (PAL-M) during a 90-minute assessment. 17 Participant age at Turner syndrome diagnosis was unknown to therapists at time of instrument administration.
Researchers conducted semistructured interviews to collect data on height, race, education, employment, marital status, age at evaluation, and age of Turner syndrome diagnosis. NIH Electronic Medical Record provided history of GH use and clinician-diagnosed depression. Age at Turner syndrome diagnosis categories included early diagnosis (Turner syndrome diagnosis received before age 13 years) and late diagnosis (Turner syndrome diagnosis received at or after age 13 years). Karyotype categories included 45, X (complete deletion of 1 X-chromosome) and other (mosaicism and partial deletion within the X-chromosome). Education categories included (1) high school, General Equivalency Diploma (GED) or less, (2) some college (some college or associate's degree), and (3) college or postgraduate degree. Race categories included (1) Caucasian, (2) African American, (3) Hispanic, and (4) other (Asian, Middle Eastern, Pacific Islander, or biracial). Employment status categories included (1) part-time, (2) full-time, (3) unemployed (unemployed by choice or unable to find work), (4) other (retired, student, unable to work owing to illness), and (5) unknown (information not indicated). Marital status categories included married (current marriage or partnership) and unmarried (never married or currently separated, divorced, or widowed).
The BDI-II is a validated 21-item self-report measure of depression symptom severity at the time of administration. Items receive ratings on a 4-point scale ranging from 0 to 3, totaling a summary score ranging from 0 to 63. Total scores represent the following symptomology ranges: 0-13 minimal, 14-19 mild, 20-28 moderate, and 29-63 severe. 13 Scores of 14 or greater indicate depressive symptoms. This instrument has wellestablished psychometric properties. 18 The OSA Version 2.2 is a self-reported assessment tool used to evaluate self-perceived competence and values. Competence (21 items) addresses participant awareness of abilities regarding skills and behaviors. Items receive ratings on a scale from 1 (I have a lot of problem doing this) to 4 (I do this extremely well). Value (21 items) addresses participant-perceived importance of competence areas, on a scale of 1 (not so important) to 4 (most important). Analyses used standardized scores (range, 1-100) converted from the competence and value total scores. This instrument has well-established psychometric properties. 19 The OPHI-II Version 2.1 is a semistructured measure used to explore a therapist's perception of an individual's ability to maintain productive lifestyle patterns. It consists of 3 scales: competence (9 items), identity (11 items), and settings (9 items). Competence includes a therapist's assessment of participants' abilities, skills, and behaviors. Identity evaluates the degree to which a participant internalizes positive roles and values. The OPHI-II settings scale was not relevant to the evaluation of perceptions of the participant and, therefore, it was not included in this analysis. Analyses used standardized scores (range, 1-100) converted from the competence and identity total scores; higher scores represent greater abilities, productivity, and values. This instrument has well-established psychometric properties. 20 The PAL-M measures psychological adjustment and physical health. Each of the 34 self-reported items receives a rating on a scale from 1 (rarely) to 4 (almost always). Individual items combined to create 7 composite subscale scores: negative emotions (5 items), poor well-being (5 items), poor income management (3 items), physical symptoms (7 items), alcohol and drug problems (4 items), poor close relations (5 items), and poor child relations (5 items). Researchers added the PAL-M in March 2010; 61 participants completed this instrument.
Statistical Analyses
Shapiro-Wilk tests were used to evaluate normality of variable distribution. We used c 2 tests to assess associations between Volume 199 • August 2018
age at diagnosis and GH use, depression diagnoses, and depressive symptoms. Mann-Whitney U tests were conducted to examine group differences in depression, identity, selfperception, psychological adjustment, and GH variables. We performed binary logistic regressions to examine the likelihood of mild to severe depressive symptoms and perceptions of competence and identity in relation to age at diagnosis, while controlling for chronological age, education level, GH use, karyotype, and marital status. Perceptions of self encompasses the individual's (OSA) and therapist's (OPHI-II) evaluation of the participant. All analyses were determined significant at the 0.05 alpha level. We used SPSS 23 to conduct analyses (SPSS, Chicago, Illinois).
Results
Analyses included data from 110 participants ( Table I ). The mean ± SD age at evaluation was 42.04 ± 11.69 years (range, 22-69 years). The overall median age at Turner syndrome diagnosis was 12.0 years (range, 0-43 years). In accordance with diagnoses categorization, 58 women received an early diagnosis, and 52 received a late diagnosis. The median ages of individuals at early and late diagnoses was 1.50 and 16.25 years, respectively. Participants were predominantly Caucasian (87.3%) and unmarried (60.9%). A majority had the 45,X karyotype (70.0%) and did not use GH treatments (64.5%). At the time of evaluation, more than one-half of the sample had a college or postgraduate degree (54.5%) and worked full-time (56.4%).
In the overall sample, 25.5% of women had mild to severe depressive symptoms, whereas depressive symptoms occurred in 12.1% of early diagnosis individuals and 40.4% of late diagnosis individuals. Unadjusted comparisons displayed that those with a late Turner syndrome diagnosis had significantly higher BDI-II scores than those diagnosed early (P = .0007). Late Turner syndrome diagnosis was significantly associated with mild to severe depressive symptoms (P = .001; Table II ). There was no association between age at diagnosis and clinician-diagnosed depression (P = .68).
As seen in Table III , participants who had a late diagnosis displayed significantly lower self-reported OSA competence scores than individuals with an early diagnosis (P = .012). There was no group difference in OSA value score (P = .555). Therapists rated those with late diagnoses significantly lower than individuals with early diagnosis on OPHI-II competence (P = .001) and identity (P = .028) scales.
The PAL-M analyses revealed that those who received a late diagnosis reported significantly higher alcohol and drug use (P = .007), and lower scores in income management (P = .025). There were no significant group differences among domains of negative emotions, well-being, or physical symptoms (Table III) . A majority of participants did not have a partner or children, resulting in low frequency of responses to PAL-M 
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close relations (n = 38) and child relations (n = 14) scales; therefore, these 2 subscales were not analyzed. Covariate-adjusted comparisons showed that late diagnosis was significantly associated with an increased likelihood of developing mild to severe depressive symptoms (OR, 7.36; P = .001) and a decreased likelihood of receiving a high therapist-rated competence score (OR, 0.26; P = .004). Age at diagnosis was not significantly associated with OSA competence (P = .08) or OPHI-II identity (P = .941; Table IV) in adjusted models.
Early diagnosis was significantly associated with a history of GH treatment (P = .001). Among individuals diagnosed early, there was a significant height difference (7.5 cm) between those who reported GH use and those who did not (P = .0007). Among individuals with a late diagnosis, there was no height difference between those who reported GH use and who did not (P = .09). A comparative analysis showed no significant difference in height between GH users and non-GH users within the entire sample (P = .67).
Discussion
Previous studies have reported psychosocial difficulties among women with Turner syndrome. 7, 9, 21 We have shown that time of diagnosis is a factor in psychosocial development among the population with Turner syndrome. Studies report a decrease in age at time of Turner syndrome diagnosis; however, approximately 47% of this sample received diagnoses at or after 13 years of age. 22 In comparison with the early diagnosis group, results indicate that women who experienced a late Turner syndrome diagnosis (1) were more likely to develop depressive symptoms, (2) reported more frequent substance use, (3) showed decreased perception of competence, and (4) engaged in GH treatment less often.
Although 40% of women with late diagnoses reported mild to severe depressive symptoms, less than 20% had cliniciandiagnosed depression. This sample's proportion of cliniciandiagnosed depression was lower than the lifetime major depression seen in 36% of women with Turner syndrome, as reported by Cardoso et al. 23 Previous studies have reported subsyndromal depressive symptoms in women with Turner syndrome; thus, those diagnosed late may experience depressive symptoms at a threshold that is prominent, but does not meet the severity necessary for a clinical diagnosis. 9, 21 Our findings indicated that those diagnosed late reported more severe feelings of self-dislike, worthlessness, personal failure, and suicidal thoughts, as identified by the BDI-II. Regardless of the absence of clinically diagnosed depression, mild to severe depression displayed in individuals with a late diagnosis may indicate a concerning psychological profile that would warrant regular mental health screenings.
Greater depression in women with late diagnoses could be a consequence of potential or existing Turner syndrome comorbidities (eg, cardiac and renal anomalies, diabetes). 24 Simultaneous disclosure of severe medical conditions associated with Turner syndrome can be devastating to quality of life. Furthermore, a delayed Turner syndrome diagnosis may render preventive treatment options inapplicable, causing women with Turner syndrome to sense a loss of control over their well-being. In cases where preventive measures are still an option, intense medical treatment for associated sequela can place mental and physical demands on women with Turner syndrome. For many, childbearing is significant to a woman's identity, relationship, and culture. Therefore, disclosure of infertility can also result in vulnerability to depression. Schmidt et al emphasized this finding, identifying similar depression profiles between women with Turner syndrome and those with premature ovarian failure. 25 Potentially, women with a late diagnosis of Turner syndrome experience depressive symptoms after acknowledging the realities of the disorder (eg, infertility, health complications). The current study did not collect data on past or current health conditions; however, future studies may consider gathering medical history to evaluate relationships among age at diagnosis, depression, and comorbidities.
Johannessen et al reported that women and girls without Turner syndrome, but with depressive symptoms, are likely to engage in frequent alcohol consumption and intoxication. 26 These researchers reference the self-medication hypothesis as a possible explanation, which is described as a person's use of substances to decrease emotional distress. 27 The present study suggests that individuals with a late diagnosis may engage in substance use to mitigate negative emotions stemming from a Turner syndrome diagnosis. Few reports are available on the frequency of alcohol and drug use among the population with Turner syndrome; however, substance use is common in individuals exhibiting depressive symptoms. 26 Additional studies are necessary to analyze the prevalence of alcohol and substance use in women with Turner syndrome.
Poor self-perception is a widely recognized issue among the population with Turner syndrome; studies indicate concerns with body image, infertility prognosis, and acceptance of Turner syndrome limitations. 10, 21, 28 Although the current study's comparative analyses showed differences in identity in relation to age at Turner syndrome diagnosis, these differences did not sustain after controlling for various factors. Instead, these findings indicate that marital status and chronological age affected identity to a greater extent than age at Turner syndrome diagnosis (Table IV) . Self-perceived competence was also not significantly associated with age at diagnosis. However, both adjusted and unadjusted models showed that therapists perceived the competence of women with late diagnoses as lower than women diagnosed early. Therapists perceived individuals with a late diagnosis as less capable of meeting expectations, fulfilling goals, and addressing responsibilities. Based on these objective evaluations, there may be salient differences in abilities between those diagnosed early and late. Studies show women with Turner syndrome benefit from therapeutic interventions promoting self-management skills; however, these interventions ameliorate difficulties only after they have already been embedded. 29 Early detection may allow time for girls with Turner syndrome to develop compensatory strategies from a young age.
The pursuit of available treatment offers a sense of control over a chronic disorder. Early diagnosis may permit the timely induction of puberty, allowing girls with Turner syndrome to develop secondary sex characteristics alongside their peers. Additionally, previous reports identified a positive relationship between growth-promoting treatments and self-perception of intelligence and attractiveness in girls with Turner syndrome. 30 Unfortunately, growth-promoting options become less effective and pursued as age at treatment initiation increases. 5 The present study's results support this observation; significantly more women with an early diagnosis received GH therapy (50%) compared with late diagnosis GH users (10%). Although some studies report that older girls with Turner syndrome may still benefit from GH treatment, early initiation positively affects height. 4, 5 For this reason, clinical practice guidelines strongly recommend that GH initiation occurs no later than age 13 years for girls to see benefit. 31 Those diagnosed early have the potential to benefit from improved body image through growth-promoting treatments, as opposed to those with a late diagnosis, who likely missed the age at which GH treatment is most effective. Future studies may consider collecting growth rate and severity of Turner syndrome clinical features in childhood to explore the relationships between childhood Turner syndrome presentation, depression, and perceptions of self.
There are limitations within the present study. The sample's small size (n = 110) may contribute to wide logistic analyses confidence intervals (Table IV) . Late inclusion of the PAL-M measures resulted in smaller sample sizes in analyses of psychosocial adjustment and physical health (n = 61). Furthermore, the PAL-M intended to provide preliminary data on alcohol and substance use in women with Turner syndrome. Future studies should use an instrument with high validity to examine these variables further. Additionally, the demographic interview did not inquire about several potentially impactful variables. For example, this study was unable to control for health care access, which could potentially influence timing of Turner syndrome diagnosis (ie, availability of diagnostic technology, socioeconomic status). This study also did not collect data on the influence or proximity of other psychosocial events (ie, losses, financial stressors, job difficulties, divorce). These factors warrant acknowledgement in future studies, because they may also contribute to depressive symptoms. Additionally, several of this study's measures included self-report questionnaires, introducing potential report and recall biases. This study also recruited on a voluntary basis, and the results potentially represent a demographically skewed sample. For example, this sample was predominately Caucasian (87%) with college or postgraduate degrees (54.5%); therefore, results potentially best depict the psychosocial characteristics of well-educated Caucasian women with Turner syndrome.
Nevertheless, these data indicate that a late diagnosis is associated with adverse psychosocial outcomes for women with Turner syndrome. Therefore, this study concludes that early childhood is a vital time for Turner syndrome diagnosis for individuals to adjust to their prognoses and consider growthpromoting treatments. Based on these study results, we recommend that pediatricians karyotype females with unexplained short stature, amenorrhea, pubertal delays, or other Turner syndrome-related features. 22 Results also highlight the need for pediatricians to regularly screen for depressive symptoms and substance use in all females with Turner syndrome, especially those who received a diagnosis at or after 13 years of age. Finally, physicians should refer females with Turner syndrome to appropriate specialists to meet their psychological needs and provide a better quality of life. ■
